Permanent Representative of INSERM Transfert Initiative
As an oncology physician and former clinical Senior Registrar at the Gustave Roussey Institute, with an MBA from the Massachusetts Institute of Technology, Dr. Thomas is Director General of the Inserm Transfer Initiative (ITI) Funds. In addition to his medical experience, his multi-disciplinary experience has led him to positions of Clinical Development Director for the Ipsen Company, Management Associate for Bioserve Ltd Consulting Company, Director of Licenses and Medical Affairs for Genset, and the Chairman of Cynthéris. He has also been involved in the Atlas Venture Investment Funds and is Head of Corporate Financial Activities for Health at Bryan Garnier. In the last 15 years, he has been dedicated mostly to creating and developing biotechnology companies in Europe.